ResearcherStanford MedicineNo recent work listed

Xiaoming Ouyang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6632-3190; OpenAlex author ID A5057525911. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. Co-author DOI 10.1016/j.stemcr.2021.04.004 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Edgar G. Engleman · 1 shared paper, 2021 · strength 0.11
- Paper Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. DOI 10.1016/j.stemcr.2021.04.004 ↗
Aida Habtezion · 1 shared paper, 2021 · strength 0.11
- Paper Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. DOI 10.1016/j.stemcr.2021.04.004 ↗
Joseph C. Wu · 1 shared paper, 2021 · strength 0.11
- Paper Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. DOI 10.1016/j.stemcr.2021.04.004 ↗
Nigel G. Kooreman · 1 shared paper, 2021 · strength 0.11
- Paper Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. DOI 10.1016/j.stemcr.2021.04.004 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.